University of Rochester (UR)

University / College


Location: Rochester, NY, United States (USA) (US) US

ISNI: 0000000419369174

ROR: https://ror.org/022kthw22

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. (2021) Mcgonagle D, Mcinnes IB, Deodhar A, Schett G, Shawi M, Kafka S, Karyekar CS, et al. Journal article Electronic Coherence and Coherent Dephasing in the Optical Control of Electrons in Graphene (2021) Heide C, Eckstein T, Boolakee T, Gerner C, Weber HB, Franco I, Hommelhoff P Journal article, Letter Artificial hyperventilation normalizes haemodynamics and arterial oxygen content in hypoxic rats (2021) De Villalobos D, Laserna A, Fowler C, Cuenca JA, Martin P, Guindani M, Dong W, et al. Journal article HAWC observations of the acceleration of very-high-energy cosmic rays in the Cygnus Cocoon (2021) Abeysekara AU, Albert A, Alfaro R, Alvarez C, Camacho JR, Arteaga-Velázquez JC, Arunbabu KP, et al. Journal article Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis (2020) Strunz M, Simon LM, Ansari M, Kathiriya JJ, Angelidis I, Mayr CH, Tsidiridis G, et al. Journal article 3HWC: The Third HAWC Catalog of Very-high-energy Gamma-Ray Sources (2020) Albert A, Alfaro R, Alvarez C, Angeles Camacho JR, Arteaga-Velazquez JC, Arunbabu KP, Avila Rojas D, et al. Journal article Machine Learning Identifies an Association Between Pre-existing Radiographic Damage and Long-term Clinical Outcomes with Secukinumab Therapy in Patients with Psoriatic Arthritis (2020) Mease P, Van Der Heijde D, Kirkham B, Schett G, Orbai AM, Ritchlin C, Merola J, et al. Conference contribution Collagen Turnover Markers Are Associated with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase-3 Clinical Trial (2020) Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Baribaud F, Sweet K Conference contribution Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety (2020) Markman JD, Bolash RB, Mcalindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer F, et al. Journal article HAWC J2227+610 and Its Association with G106.3+2.7, a New Potential Galactic PeVatron (2020) Albert A, Alfaro R, Alvarez C, Angeles Camacho JR, Arteaga-Velazquez JC, Arunbabu KP, Avila Rojas D, et al. Journal article
1 ... 3 4 5 6 7 8